Baxter International Inc
BAX30.760USD
-0.410-1.32%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
15.72BCap. mercado
PérdidaP/E TTM
Más Datos de Baxter International Inc Compañía
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Información de la empresa
Código de la empresaBAX
Nombre de la empresaBaxter International Inc
Fecha de salida a bolsaMay 15, 1961
Fundada en1931
Director ejecutivoMr. D. Brent Shafer
Número de empleados38000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 15
DirecciónOne Baxter Parkway
CiudadDEERFIELD
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal60015
Teléfono12249482000
Sitio Webhttps://www.baxter.com/
Código de la empresaBAX
Fecha de salida a bolsaMay 15, 1961
Fundada en1931
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
130.30K
+15.20%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
118.15K
+10.70%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
28.52K
+2.77%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
23.05K
+2.74%
Ms. Patricia B. Morrison
Ms. Patricia B. Morrison
Independent Director
Independent Director
15.76K
-25.89%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
9.27K
+2.46%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
3.47K
--
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
787.00
-88.29%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Heather Knight
Ms. Heather Knight
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies
177.32K
+11.79%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
130.30K
+15.20%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
118.15K
+10.70%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
28.52K
+2.77%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
23.05K
+2.74%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Infusion Therapies and Technologies
4.10B
38.58%
Care and Connectivity Solutions
1.81B
17.06%
Injectables and Anesthesia
1.37B
12.91%
Front Line Care
1.14B
10.69%
Advanced Surgery
1.10B
10.38%
Other
1.10B
10.39%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
5.85B
55.00%
International
4.79B
45.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Infusion Therapies and Technologies
4.10B
38.58%
Care and Connectivity Solutions
1.81B
17.06%
Injectables and Anesthesia
1.37B
12.91%
Front Line Care
1.14B
10.69%
Advanced Surgery
1.10B
10.38%
Other
1.10B
10.39%
Accionista
Hora de actualización: hace 20 horas
Hora de actualización: hace 20 horas
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
11.80%
Dodge & Cox
10.06%
Pzena Investment Management, LLC
6.56%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Global Advisors (US)
4.25%
Other
61.58%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
11.80%
Dodge & Cox
10.06%
Pzena Investment Management, LLC
6.56%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Global Advisors (US)
4.25%
Other
61.58%
Tipo
Accionista
Proporción
Investment Advisor/Hedge Fund
53.40%
Investment Advisor
32.35%
Research Firm
2.70%
Hedge Fund
2.37%
Pension Fund
2.23%
Insurance Company
1.44%
Bank and Trust
1.13%
Sovereign Wealth Fund
1.00%
Individual Investor
0.36%
Other
3.01%
Participación institucional
Hora de actualización: jue., 20 de feb
Hora de actualización: jue., 20 de feb
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1902
499.25M
97.33%
-40.58M
2024Q4
1984
501.11M
97.98%
-41.68M
2024Q3
2005
485.40M
95.14%
-42.32M
2024Q2
2042
472.72M
92.77%
-47.98M
2024Q1
2091
469.13M
92.11%
-57.76M
2023Q4
2137
471.69M
92.98%
-44.04M
2023Q3
2123
465.39M
91.91%
-35.52M
2023Q2
2140
458.55M
90.66%
-30.65M
2023Q1
2123
459.27M
90.86%
-22.24M
2022Q4
2132
456.58M
90.57%
-21.28M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
60.53M
11.8%
+468.84K
+0.78%
Dec 31, 2024
Dodge & Cox
51.58M
10.06%
+1.20M
+2.39%
Feb 28, 2025
Pzena Investment Management, LLC
33.64M
6.56%
+1.42M
+4.39%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
29.53M
5.76%
-652.43K
-2.16%
Dec 31, 2024
State Street Global Advisors (US)
21.79M
4.25%
+12.21K
+0.06%
Dec 31, 2024
BlackRock Financial Management, Inc.
17.57M
3.43%
+1.23M
+7.54%
Dec 31, 2024
T. Rowe Price Associates, Inc.
15.25M
2.97%
+1.13M
+8.03%
Dec 31, 2024
Geode Capital Management, L.L.C.
12.45M
2.43%
+290.28K
+2.39%
Dec 31, 2024
Harris Associates L.P.
8.46M
1.65%
-1.31M
-13.43%
Dec 31, 2024
Columbia Threadneedle Investments (US)
7.28M
1.42%
-2.29M
-23.93%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Parnassus Value Select ETF
5.07%
Cullen Enhanced Equity Income ETF
3.53%
iShares Large Cap Value Active ETF
2.45%
Global X S&P 500 Quality Dividend ETF
2%
iShares U.S. Medical Devices ETF
1.92%
Invesco S&P 500 Equal Weight Health Care ETF
1.76%
SPDR S&P Health Care Equipment ETF
1.52%
First Trust Indxx Medical Devices ETF
1.27%
ROBO Global Healthcare Technology & Innovation ETF
0.98%
Humankind US Stock ETF
0.85%
Ver más
Parnassus Value Select ETF
Proporción5.07%
Cullen Enhanced Equity Income ETF
Proporción3.53%
iShares Large Cap Value Active ETF
Proporción2.45%
Global X S&P 500 Quality Dividend ETF
Proporción2%
iShares U.S. Medical Devices ETF
Proporción1.92%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.76%
SPDR S&P Health Care Equipment ETF
Proporción1.52%
First Trust Indxx Medical Devices ETF
Proporción1.27%
ROBO Global Healthcare Technology & Innovation ETF
Proporción0.98%
Humankind US Stock ETF
Proporción0.85%
Dividendos
Un total de
2.75B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
May 01, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jul 03, 2023
Jun 01, 2023
Feb 14, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option
Feb 24, 2023
Apr 03, 2023
Feb 23, 2023
Nov 15, 2022
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022
Dec 02, 2022
Jan 03, 2023
Dec 01, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos